Latham Steers Cancer Therapy Biz's $200M Funding Round
Life sciences company Erasca, represented by Latham & Watkins LLP, said Monday that it had raised $200 million from backers such as ARCH Venture Partners to develop its cancer therapies, even as...To view the full article, register now.
Already a subscriber? Click here to view full article